Safe and effective medicines for children : pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act / Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equality Act (PREA), Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Marilyn J. Field and Thomas F. Boat, editors.

Bibliographic Details
Corporate Authors: Institute of Medicine (U.S.). Board on Health Sciences Policy
National Research Council (U.S.)
Other Authors: Field, Marilyn J. (Marilyn Jane) (Editor)
Boat, Thomas F. (Editor)
Language:English
Published: Washington, D.C. : National Academies Press, [2012]
Subjects:
Genre:
Physical Description:xxiii, 408 pages : illustrations ; 24 cm
Also issued online.
Format: Book

MARC

LEADER 00000cam a2200000Ii 4500
001 in00005071259
003 OCoLC
005 20220616045908.0
008 121008s2012 dcua b 100 0 eng d
020 |a 9780309225496 
020 |a 0309225493 
035 |a (CaEvSKY)SKY250894805 
035 |a (OCoLC)812189057 
040 |a NRC  |c NRC  |e rda  |d YDXCP  |d OCLCQ  |d AAA  |d PSt  |d UtOrBLW 
049 |a EEMR 
090 |a RJ560  |b .S244 2012 
245 0 0 |a Safe and effective medicines for children :  |b pediatric studies conducted under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act /  |c Committee on Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act (BPCA) and the Pediatric Research Equality Act (PREA), Board on Health Sciences Policy, Institute of Medicine of the National Academies ; Marilyn J. Field and Thomas F. Boat, editors. 
260 |a Washington, D.C. :  |b National Academies Press,  |c [2012] 
300 |a xxiii, 408 pages :  |b illustrations ;  |c 24 cm 
336 |a text  |b txt  |2 rdacontent 
337 |a unmediated  |b n  |2 rdamedia 
338 |a volume  |b nc  |2 rdacarrier 
504 |a Includes bibliographic references and index. 
505 0 |a Introduction -- Children's growth and development and pediatric drug studies -- Policy framework for BPCA and PREA -- Ethical issues in pediatric drug studies -- Safety and efficacy assessment in studies conducted under BPCA and PREA -- BPCA, PREA, and drug studies with neonates -- Outcomes of written requests, requirements, studies, and labelling changes -- Pediatric studies of biologics. 
530 |a Also issued online. 
650 0 |a Pediatric pharmacology  |v Congresses.  |0 http://id.loc.gov/authorities/subjects/sh85099170 
650 2 |a Drug Therapy. 
650 2 |a Child. 
700 1 |a Field, Marilyn J.  |q (Marilyn Jane),  |e editor.  |0 http://id.loc.gov/authorities/names/n83205699 
700 1 |a Boat, Thomas F.,  |e editor.  |0 http://id.loc.gov/authorities/names/n96802649 
710 2 |a Institute of Medicine (U.S.).  |b Board on Health Sciences Policy.  |0 http://id.loc.gov/authorities/names/no00094907 
710 2 |a National Research Council (U.S.)  |0 http://id.loc.gov/authorities/names/n79036113 
907 |y .b9760060x  |b 220315  |c 121012 
998 |a rs  |b 121012  |c m  |d a   |e -  |f eng  |g dcu  |h 0  |i 1 
999 f f |i 61918412-fe38-5694-9dc6-03ea984703ec  |s 5a9d24bd-24d5-5d55-9097-8fc03576fcc7  |t 0 
952 f f |p Can Circulate  |a Michigan State University-Library of Michigan  |b Michigan State University  |c MSU Remote Storage  |d MSU Remote Storage  |t 0  |e RJ560 .S244 2012  |h Library of Congress classification  |i Printed Material  |m 31293032718037  |n 1